Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,875 | 343 | 96.5% |
| Education | $178.99 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $697.59 | 66 | $0 (2024) |
| Lilly USA, LLC | $676.94 | 46 | $0 (2024) |
| PFIZER INC. | $580.95 | 51 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $544.15 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $390.77 | 20 | $0 (2024) |
| GENZYME CORPORATION | $300.55 | 17 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $213.99 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $167.73 | 5 | $0 (2024) |
| LEO Pharma Inc. | $163.63 | 10 | $0 (2024) |
| Galderma Laboratories, L.P. | $158.13 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,044 | 132 | Lilly USA, LLC ($364.02) |
| 2023 | $1,234 | 84 | Sun Pharmaceutical Industries Inc. ($220.25) |
| 2022 | $917.33 | 58 | Regeneron Healthcare Solutions, Inc. ($235.16) |
| 2021 | $165.82 | 12 | PFIZER INC. ($43.77) |
| 2020 | $86.24 | 6 | Lilly USA, LLC ($27.42) |
| 2019 | $400.50 | 35 | PFIZER INC. ($174.29) |
| 2018 | $205.74 | 18 | PFIZER INC. ($108.60) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $33.81 | General |
| 12/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Immunology | ||||||
| 12/11/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $9.56 | General |
| 12/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Inflammation & Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 11/13/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $4.50 | General |
| 11/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Inflammation & Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 660 | 1,095 | $235,840 | $55,806 |
| 2022 | 9 | 477 | 707 | $159,185 | $40,086 |
| 2021 | 7 | 198 | 305 | $36,195 | $17,173 |
| 2020 | 7 | 276 | 448 | $53,100 | $19,896 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 202 | $39,390 | $14,538 | 36.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 116 | 145 | $72,500 | $14,023 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 71 | $15,975 | $6,855 | 42.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 80 | 93 | $32,550 | $6,218 | 19.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 87 | 113 | $33,900 | $4,378 | 12.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $11,500 | $4,104 | 35.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 61 | 347 | $17,350 | $2,065 | 11.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 39 | $5,850 | $1,908 | 32.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 27 | 39 | $6,825 | $1,717 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 143 | $27,135 | $10,408 | 38.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 79 | 103 | $49,850 | $10,020 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 69 | 74 | $25,300 | $5,615 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 50 | $11,190 | $5,080 | 45.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 68 | 81 | $22,770 | $3,248 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $8,550 | $3,006 | 35.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 45 | 185 | $8,550 | $1,131 | 13.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 14 | 20 | $3,500 | $956.66 | 27.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $2,340 | $621.96 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 55 | $7,975 | $4,542 | 57.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 32 | 34 | $7,650 | $3,622 | 47.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $4,730 | $2,558 | 54.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 26 | $5,200 | $2,178 | 41.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $4,410 | $2,130 | 48.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 33 | 35 | $4,550 | $1,450 | 31.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 23 | 112 | $1,680 | $693.50 | 41.3% |
About Dr. Suzanne Dundon, M.D
Dr. Suzanne Dundon, M.D is a Dermatology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1699902528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Dundon, M.D has received a total of $5,054 in payments from pharmaceutical and medical device companies, with $2,044 received in 2024. These payments were reported across 345 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,875).
As a Medicare-enrolled provider, Dundon has provided services to 1,611 Medicare beneficiaries, totaling 2,555 services with total Medicare billing of $132,961. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Dayton, OH
- Active Since 06/18/2009
- Last Updated 10/27/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1699902528
Products in Payments
- DUPIXENT (Biological) $741.76
- EUCRISA (Drug) $502.30
- RINVOQ (Biological) $454.24
- TALTZ (Drug) $444.35
- ILUMYA (Biological) $256.12
- SKYRIZI (Biological) $229.35
- Winlevi (Drug) $213.25
- OLUMIANT (Drug) $166.62
- ADBRY (Biological) $163.63
- OPZELURA (Drug) $156.42
- TREMFYA (Drug) $150.85
- Bimzelx (Biological) $140.74
- COSENTYX (Drug) $104.37
- Sotyktu (Drug) $91.89
- JUBLIA (Drug) $91.32
- DORYX (Drug) $90.11
- EPIDUO FORTE (Drug) $82.33
- CIBINQO (Drug) $78.65
- Otezla (Drug) $73.40
- EBGLYSS (Drug) $65.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dayton
Rocco Serrao, Md, MD
Dermatology — Payments: $1.5M
Dr. Matthew Bakos, M.d, M.D
Dermatology — Payments: $146,885
Jeffrey Travers, Md, Ph.d, MD, PH.D
Dermatology — Payments: $108,675
Shannon Verma, M.d, M.D
Dermatology — Payments: $12,575
Dr. Brian Russ, M.d, M.D
Dermatology — Payments: $11,676
Bruce Brumfiel, M.d, M.D
Dermatology — Payments: $11,071